Remember Woodford, and make sure you can cash out
Investing is full of risks. But not being able to sell your investment when you want to is one you shouldn't have to deal with, says Merryn Somerset Webb.


There are plenty of ways to lose money right now – you might be down 30% on fintech stocks; you may own the Nasdaq Golden Dragon China index (up a lot this week, but still down more than 60% in a year); or you may just have had rather too much of the one-time high-flying Scottish Mortgage Investment Trust in your portfolio – and be down 30% in the last six months. But for all the miseries of this kind of disaster, they do have an upside: you can sell and take what cash you have left any time you like (whether you should or not is a different conversation), and move on.
That is not the case if you were an investor in the Woodford Equity Income fund. The fund was suspended in June 2019. Its manager, Neil Woodford (once considered the UK’s best fund manager), had used it to buy a pile of small, illiquid stocks (which did not produce an income!) that he was then unable to sell in a hurry when his lousy performance prompted investors to demand their money back.
Always have an escape route
The idea was that the suspension would give Link – who fired Woodford and took over managing the fund – breathing space to sell the assets and return the cash. Three years later it is still at it. It’s sold £2.5bn-worth of shares, but the final stocks still aren’t sold; investors haven’t seen a penny for 15 months and there is no obvious end-date. Sales will continue, says Link, but “at a pace which seeks to achieve the best outcome for investors”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Link’s definition of “best” may differ from ours. Best would have been intervening before the fund was so obviously in trouble back in 2019. Best after that would have been selling the first lot of assets at prices closer to their actual value (that it did not was all too plain in the prices the first round of buyers got when they flipped them on). Best after that would have been finding a way to sell the leftovers into the private-equity and small-cap growth euphoria at the end of last year.
Good luck getting a nice price (they are valued at £141m) now – as Link is honest enough to say, thanks to the “nature and maturity of some of the remaining assets their valuations may fall as well as rise”. Even if they do not fall, investors will have received back £1bn less in total than the supposed value of the fund the day it was suspended. Finally I think that, Link aside, we can all agree that “best” should surely mean bringing the whole sorry saga to an end in under three and a half years.
The only positive I can pull from all this is that the regular, grim updates from Link act as a constant reminder that there are two kinds of risk in investing. The first is the one most of us are dealing with now (volatile markets) – no one is to blame for that (except central bankers – we will return to that another day). The second is getting caught in the wrong structure and not being able to get out. Woodford offered the best example of how careful you have to be (he’ll be pleased to have been best at something), but we’ve seen it again in the last two weeks: many funds with Russian exposure have been frozen. We have long favoured investment trusts over open-ended funds – the ability to sell at any time is one big reason why. I’m not thrilled to have JPMorgan Russian Securities in my portfolio (it is down 86% in a month). But I am at least pleased to have the freedom to sell the remaining 15% without any input from Link.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Merryn Somerset Webb started her career in Tokyo at public broadcaster NHK before becoming a Japanese equity broker at what was then Warburgs. She went on to work at SBC and UBS without moving from her desk in Kamiyacho (it was the age of mergers).
After five years in Japan she returned to work in the UK at Paribas. This soon became BNP Paribas. Again, no desk move was required. On leaving the City, Merryn helped The Week magazine with its City pages before becoming the launch editor of MoneyWeek in 2000 and taking on columns first in the Sunday Times and then in 2009 in the Financial Times
Twenty years on, MoneyWeek is the best-selling financial magazine in the UK. Merryn was its Editor in Chief until 2022. She is now a senior columnist at Bloomberg and host of the Merryn Talks Money podcast - but still writes for Moneyweek monthly.
Merryn is also is a non executive director of two investment trusts – BlackRock Throgmorton, and the Murray Income Investment Trust.
-
How Corpay is cashing in on expenses
Financial technology company Corpay has found a profitable niche managing corporate payments
By Dr Matthew Partridge Published
-
Are UK Reits the most unloved asset?
Recent updates from UK Reits are looking more positive, but the market remains entirely unimpressed
By Cris Sholto Heaton Published
-
Why CEOs deserve a pay rise
Opinion The CEOs of big companies often come under fire for being grossly overpaid. But the truth, as per some economists, is the opposite. Do they merit a pay rise?
By Stuart Watkins Published
-
Rolls-Royce stock jumps 15% – could it climb further?
Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
By Dr Matthew Partridge Published
-
The power of private markets
Interview Helen Steers, co-manager of the Pantheon International investment trust, tells MoneyWeek about the vast array of compelling opportunities in private equity
By Andrew Van Sickle Published
-
Vertex Pharmaceuticals is an uncommon opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success
By Dr Mike Tubbs Published
-
Global investors have overlooked these top tips in emerging markets
Opinion Chris Tennant, co-portfolio manager of Fidelity Emerging Markets, picks three attractive companies in emerging markets
By Chris Tennant Published
-
King Coal has not been dethroned yet — should you buy?
The demand for coal is only growing, yet investors don’t seem to want to take advantage of the opportunity, says Rupert Hargreaves
By Rupert Hargreaves Published
-
It’s time to start buying Europe again, says Merryn Somerset Webb
Opinion Europe's stocks are cheap and the economic backdrop is starting to look cheerier, says Merryn Somerset Webb
By Merryn Somerset Webb Published
-
Prosus to buy Just Eat for €4.1 billion as takeaway boom fades
Food-delivery platform Just Eat has been gobbled up by a Dutch rival. Now there could be further consolidation in the sector
By Dr Matthew Partridge Published